Pliant Therapeutics (PLRX) Interest & Investment Income (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Interest & Investment Income of $1.7 million for Q1 2026, up 1169.14% year-over-year from $136470.8 in Q1 2025, and down 85.2% quarter-over-quarter from $11.7 million in Q4 2025.
Pliant Therapeutics (PLRX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Interest & Investment Income for 8 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 1169.14% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $13.3 million (up 1954.01% YoY), while the FY2025 annual figure was $11.4 million, up 47666.67% from the prior year.
- Interest & Investment Income retreated to $1.7 million in Q1 2026 per PLRX's latest filing, from $11.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $11.7 million in Q4 2025 and bottomed at -$15.5 million in Q4 2023.
- Historically, Interest & Investment Income has averaged -$241529.4 across 5 years, with a median of -$160000.0 in 2025.
- Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 5450.0% — and 2025, when it jumped 2320.68%.
- Pliant Therapeutics' Interest & Investment Income stood at $496000.0 in 2022, then sank by 3229.84% to -$15.5 million in 2023, then surged by 96.61% to -$527000.0 in 2024, then surged by 2320.68% to $11.7 million in 2025, then slumped by 85.2% to $1.7 million in 2026.
- Business Quant data shows PLRX's Interest & Investment Income at $1.7 million in Q1 2026, $11.7 million in Q4 2025, and $35000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 11.70 Mn |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Mar 31, 2025 | -162,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | -128,000.00 |
| Mar 31, 2024 | -834,000.00 |
| Dec 31, 2023 | -15.52 Mn |
| Sep 30, 2023 | 334,000.00 |
| Jun 30, 2023 | -910,000.00 |
| Mar 31, 2023 | 627,000.00 |
| Dec 31, 2022 | 496,000.00 |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -309,000.00 |
| Mar 31, 2022 | -749,000.00 |
| Dec 31, 2021 | -161,000.00 |
| Sep 30, 2021 | 68,000.00 |